How much sleep for a healthy heart and arteries: what science says

Quanto dormire per cuore e arterie in salute: che cosa dice la scienza

Updated and contextualized version of an article originally published on March 18, 2014
The article retains its original focus by presenting it through a scholarly and accessible perspective, supported by verifiable references.


Authors

  • Dr. A. Conte – Biologist
  • Roberto Panzironi –Independent researcher 

Note editoriali

  • First publication: March 18, 2014
  • Last update: April 18, 2026
  • Version: 2026 narrative revision  

[Note: This article is an update of previously published content. It has been revised following scientific and informative criteria. The information provided is for informational purposes only and does not replace the advice of a doctor.]

IN BRIEF

  • Most observational evidence finds a U-shaped relationship between sleep duration and cardiovascular risk: both very short and very long sleep are associated with increased risk.
  • Nightly sleep around 7–8 hours is frequently indicated as the range associated with the lowest cardiovascular risk in the general adult population.
  • Many studies rely on self-reported sleep: objective data (actigraphy, polysomnography) can produce different results and complete the picture.
  • Plausible mechanisms include inflammation, blood pressure alterations, and arterial stiffness, but most evidence is observational and does not demonstrate direct causality.

Abstract: what does science say?

Simple definition: sleep duration indicates the total time spent sleeping in a 24-hour cycle, typically measured per night. Observational research on hundreds of thousands or millions of people shows a non-linear association between hours of sleep and the risk of cardiovascular events and mortality.

Main evidence: meta-analyses and large cohort studies suggest that the risk is lowest for those who sleep in a range of about 7–8 hours; both regularly sleeping fewer and more hours are associated with a relative increase in risk. However, these results predominantly come from observational studies and subjective self-reports of sleep.

Context and measurement dependence: the strength of the association varies depending on how sleep is measured (self-report vs. objective measures), the presence of insomnia or sleep apnea, comorbidities, and daytime habits (e.g., naps), and differs by age and geographical populations.

Interpretive limitations: the evidence is consistent in documenting associations but does not prove that modifying sleep duration directly causes a reduction in cardiovascular events. Additional analyses with objective measures, longitudinal design, and approaches that approximate causality are needed.

What is meant by "sufficient sleep"?

In the literature, sufficient sleep refers to a nocturnal duration within the range associated with lower risk in large observational studies — often indicated as 7–8 hours for most adults. This definition is epidemiological and does not account for individual biological needs: some people may feel rested with slightly different times. Sleep quality (continuity, awakenings, feeling rested) is complementary to duration and can modify risk estimates.

What does the available evidence show?

Numerous cohort studies and meta-analyses have reported a U-shaped curve: both very short and very long durations are associated with a relative increase in the risk of cardiovascular events and mortality. Extensive dose-response analyses suggest a minimum risk point around 7–7.5 hours per night in the general population. However, sleep measurement and variability among populations explain some of the differences between studies.

What factors modulate the effect?

The relationship depends on: sleep measurement method (self-reported vs. objective), presence of sleep disorders (e.g., obstructive sleep apnea, insomnia), age, comorbidities (diabetes, hypertension), daytime behavior (physical activity, napping), and socioeconomic factors. Therefore, the estimates for "7 hours" are population averages and not individual prescriptions.

MAIN SECTION

What the Dutch study says and how it fits into the picture

At the origin of the topic is a study conducted in the MORGEN cohort (Netherlands) which evaluated, in over 14,000 participants followed for years, the impact of sleep duration along with other lifestyle factors on cardiovascular risk: participants who reported at least 7 hours of sleep showed a reduced risk compared to those who slept less, and the addition of sufficient sleep to traditional prevention factors (physical activity, diet, moderate alcohol consumption, not smoking) was associated with a further reduction in the overall risk of the cohort [1].

This result is consistent with broader literature highlighting a non-linear relationship between sleep duration and cardiovascular risk: previous and subsequent meta-analyses have identified an increased incidence of events for durations significantly less than 7 hours and for durations greater than 8–9 hours in many contexts [2][3][4].

It is important to emphasize that the MORGEN study is observational: it shows associations and estimates the theoretical impact on the population, but it does not prove that increasing or decreasing sleep hours in individuals causally modifies the risk of a cardiovascular event.

Overall evidence and dose-response analysis

More recent systematic reviews and dose-response meta-analyses, based on millions of participants, describe a minimum risk around 7–7.5 hours per night; both chronic sleep deprivation and prolonged durations show associations with adverse outcomes, with U- or J-shaped curves depending on the populations considered [4][6].

At the level of large international cohorts, including multicenter studies of tens of thousands of people, a similar trend is observed: the optimal point estimate is frequently between 6 and 8 hours of nightly sleep, with a progressive increase in risk outside this range [5].

Plausible biological mechanisms

The biological plausibility linking poor or fragmented sleep to cardiovascular disease includes: elevated inflammatory biomarkers, alterations in autonomic control and nocturnal blood pressure, endothelial dysfunction, and increased arterial stiffness. Experimental and observational studies have documented increases in neutrophils and inflammatory signals associated with fragmented sleep, which in turn correlate with signs of subclinical atherosclerosis [8][9].

What is the strongest evidence?

The most robust evidence comes from meta-analyses of prospective cohorts and multicenter studies with prolonged follow-up: these sources agree on the presence of associations but remain limited by the observational nature of the data and the prevalent reliance on self-reported sleep. Studies with objective measures and approaches that reduce bias (e.g., Mendelian randomization, targeted clinical interventions) provide additional elements but are not yet sufficient to define clear causal relationships in the general population [3][4][7].

PRACTICAL SECTION

What it means in practice

For the health-conscious reader: evidence suggests that, at a population level, regularly sleeping around 7–8 hours per night is associated with a lower cardiovascular risk profile compared to significantly shorter or very prolonged durations. This is not a medical prescription: the optimal duration can vary by age, clinical conditions, and individual needs.

In the context of cardiovascular prevention, it is reasonable to consider sleep as a component of lifestyle along with diet, physical activity, weight control, not smoking, and limiting alcohol. If daytime sleepiness, frequent awakenings, suspected sleep apnea, or a feeling of not being rested are present, it is advisable to consult a doctor or sleep specialist for further investigation, as many treatable conditions can affect risk.

For the general population, established strategies (regular hours, sleep-friendly environment, limiting screens before bed, regular physical activity) can promote sleep duration and quality with probable benefits for cardiovascular health. However, it is still necessary to avoid overly simplistic conclusions: the observed associations do not authorize considering the sole modification of sleep duration as a guaranteed intervention to reduce individual cardiovascular risk.

KEY POINTS TO REMEMBER

  • Observational literature indicates a U-shaped relationship between sleep duration and cardiovascular risk: the range around 7–8 hours is associated with the lowest risk in the general population [4].
  • Many studies are based on self-reported sleep; objective measures and quality assessment are complementary and sometimes lead to different estimates [3].
  • Plausible mechanisms include inflammation, nocturnal blood pressure alterations, and arterial stiffness, but proof of causality is limited [8][9].
  • For cardiovascular prevention, sleep should be considered along with other lifestyle factors; sleep disorders should be clinically evaluated.

Limitations of the evidence

Most available research is observational: it documents associations but does not prove causality. The main limitations include the prevalent use of self-reported sleep (susceptible to bias), variability in duration categories between studies, potential residual confounding factors (pre-existing health, inaccuracies in behavioral measures), and variability among populations. Furthermore, the relationship can be influenced by specific conditions (e.g., obstructive sleep apnea, chronic diseases) that alter both sleep and cardiovascular risk.

Editorial conclusion

Current evidence supports the inclusion of sleep duration and quality in the assessment of cardiovascular health at the population level. Although the 7–8 hours per night range is indicated as associated with the lowest risk in most studies, it is crucial to interpret these results with caution: these are epidemiological estimates, not binding clinical recommendations. For individual patients, personalized medical evaluation remains essential. Future research should continue with objective measures, well-designed longitudinal studies, and targeted interventions to clarify if and how modifying sleep can translate into a real reduction in cardiovascular risk.

Editorial transparency

This update has been prepared following criteria of accuracy, transparency, and traceability of sources. The cited research is all peer-reviewed and accompanied by verifiable DOIs in the Scientific Research section. The article is informative: it does not constitute clinical advice or replace the relationship with the treating physician. Any conflicts of interest related to this content are absent, and the review has prioritized primary sources and systematic reviews.

Editorial note

This article is derived from previously published text and has been updated to reflect the latest scientific literature and best editorial practices: clarity of language, distinguishing associations from causality, and providing verifiable references (DOI). The goal is to inform the general public with rigor and sobriety, emphasizing bibliographic transparency. For individual clinical decisions, always consult a qualified healthcare professional.

SCIENTIFIC RESEARCH

  1. Hoevenaar-Blom MP, et al. Sufficient sleep duration contributes to lower cardiovascular disease risk in addition to four traditional lifestyle factors: the MORGEN study. European Journal of Preventive Cardiology. doi: https://doi.org/10.1177/2047487313493057. [1]
  2. Cappuccio FP, et al. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. European Heart Journal. doi: https://doi.org/10.1093/eurheartj/ehr007. [2]
  3. Lewis A, et al. Self-Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose-Response Meta-Analysis. Journal of the American Heart Association. doi: https://doi.org/10.1161/JAHA.118.008552. [3]
  4. Huang Y-M, et al. Sleep duration and risk of cardio-cerebrovascular disease: A dose-response meta-analysis of cohort studies comprising 3.8 million participants. Frontiers in Cardiovascular Medicine. doi: https://doi.org/10.3389/fcvm.2022.907990. [4]
  5. Wang C, et al. Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116,632 people from 21 countries. European Heart Journal. doi: https://doi.org/10.1093/eurheartj/ehy695. [5]
  6. Jike M, Itani O, Watanabe N, Buysse DJ, Kaneita Y. Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression. Sleep Medicine Reviews. doi: https://doi.org/10.1016/j.smrv.2017.06.011. [6]
  7. UK Biobank cohort study. Associations of sleep duration and quality with incident cardiovascular disease, cancer, and mortality: a prospective cohort study. Sleep. doi: https://doi.org/10.1016/j.sleep.2021.03.015. [7]
  8. Vallat R, Shah VD, Redline S, Attia P, Walker MP. Broken sleep predicts hardened blood vessels. PLOS Biology. doi: https://doi.org/10.1371/journal.pbio.3000726. [8]
  9. Pomeroy A, et al. The relationship between sleep duration and arterial stiffness: A meta-analysis. Sleep Medicine Reviews. doi: https://doi.org/10.1016/j.smrv.2023.101794. [9]